PMLiVE30m
Biogen/Eisai’s Alzheimer’s drug approved by FDA for monthly maintenance dosing
Biogen and Eisai’s Alzheimer’s disease (AD) drug Leqembi (lecanemab-irmb) has been approved by the US Food and Drug ...
PMLiVE31m
Pfizer shares positive late-stage results for Braftovi regimen in colorectal cancer
Pfizer has shared positive results from a late-stage study of its Braftovi (encorafenib) combination in BRAF V600E-mutant ...
PMLiVE34m
Promiscuous strategists
Rather, I was suggesting that he use the metaphor of promiscuous enzymes, a concept I’d learned from Andreas Wagner’s ...
PMLiVE32m
Havas Health Network launches Havas Life London
Havas Health Network has launched Havas Life London, an evolution of Havas Life Medicom that is “deeply rooted” in the agency ...